Impaired Expression of Humanin during Adrenocortical Carcinoma
International Journal of Molecular Sciences · 15.01.2024 · 25 (2) · 1038
DOI: 10.3390/ijms25021038 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.01.2024. Verfasst von Małgorzata Blatkiewicz und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznan, Poland. Hauptthemen laut MEDLINE: Adrenocortical Carcinoma, Adrenal Cortex Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Center, National Science Centre.
Abstract (Originalsprache)
The discovery of mitochondria-derived peptides (MDPs) has provided a new perspective on mitochondrial function. MDPs encoded by mitochondrial DNA (mtDNA) can act as hormone-like peptides, influencing cell survival and proliferation. Among these peptides, humanin has been identified as a crucial factor for maintaining cell survival and preventing cell death under various conditions. Adrenocortical carcinoma (ACC) is a rare and aggressive malignancy that results from adrenal hormone dysfunction. This study aimed to investigate humanin expression in the adrenal tissue and serum of patients with ACC. For the first time, our study revealed significant reduction in the mRNA expression of humanin in patients with ACC compared to healthy controls. However, no significant changes were observed in the serum humanin levels. Interestingly, we identified a positive correlation between patient age and serum humanin levels and a negative correlation between tumor size and LDL levels. While the impaired expression of humanin in patients with ACC may be attributed to mitochondrial dysfunction, an alternative explanation could be related to diminished mitochondrial copy number. Further investigations are warranted to elucidate the intricate relationship among humanin, mitochondrial function, and ACC pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Poznan University of Medical Sciences, 60-781 Poznan, Poland.
- Doctoral School, Poznan University of Medical Sciences, 60-812 Poznan, Poland.
- Department of Endocrinology, Metabolism and Internal Medicine, Poznan University of Medical Sciences, 60-356 Poznan, Poland.
- Department of Anatomy and Histology, University of Zielona Góra, Licealna Street 9, 65-417 Zielona Góra, Poland.
- Department of General, Endocrinological and Gastroenterological Surgery, Poznan University of Medical Sciences, 60-355 Poznan, Poland.
- Department of General and Transplantation Surgery, Poznan University of Medical Sciences, 60-356 Poznan, Poland.
ORCID-Profile: Małgorzata Blatkiewicz, Marta Szyszka, Anna Olechnowicz, Karol Jopek, Hanna Komarowska, Marianna Tyczewska, Marek Ruchała, Marcin Rucinski
Förderung
- National Science Center
- National Science Centre
Zitieren
APA
Blatkiewicz, M., Szyszka, M., Olechnowicz, A., Kamiński, K., Jopek, K., Komarowska, H., Tyczewska, M., Klimont, A., Wierzbicki, T., Karczewski, M., Ruchała, M., & Rucinski, M. (2024). Impaired Expression of Humanin during Adrenocortical Carcinoma. International Journal of Molecular Sciences, 25(2), 1038. https://doi.org/10.3390/ijms25021038
Vancouver
Blatkiewicz M, Szyszka M, Olechnowicz A, Kamiński K, Jopek K, Komarowska H, et al. Impaired Expression of Humanin during Adrenocortical Carcinoma. International Journal of Molecular Sciences. 2024;25(2):1038. doi:10.3390/ijms25021038
BibTeX
@article{Blatkiewicz2024,
author = {Blatkiewicz, Małgorzata and Szyszka, Marta and Olechnowicz, Anna and Kamiński, Kacper and Jopek, Karol and Komarowska, Hanna and Tyczewska, Marianna and Klimont, Anna and Wierzbicki, Tomasz and Karczewski, Marek and Ruchała, Marek and Rucinski, Marcin},
title = {Impaired Expression of Humanin during Adrenocortical Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {2},
pages = {1038},
doi = {10.3390/ijms25021038}
}
EUVIMED